Literature DB >> 10082124

A predominantly HIV type 1 subtype C-restricted epidemic in South African urban populations.

J H Van Harmelen1, E Van der Ryst, A S Loubser, D York, S Madurai, S Lyons, R Wood, C Williamson.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10082124     DOI： 10.1089/088922299311376

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN： 0889-2229            Impact factor:   2.205


× No keyword cloud information.
  32 in total

1.  Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children.

Authors:  P J Goulder; C Brander; K Annamalai; N Mngqundaniso; U Govender; Y Tang; S He; K E Hartman; C A O'Callaghan; G S Ogg; M A Altfeld; E S Rosenberg; H Cao; S A Kalams; M Hammond; M Bunce; S I Pelton; S A Burchett; K McIntosh; H M Coovadia; B D Walker
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Characterisation of near-full length genome sequences of three South African human immunodeficiency virus type 1 subtype C isolates.

Authors:  Gillian M Hunt; Maria A Papathanasopoulos; Glenda E Gray; Caroline T Tiemessen
Journal:  Virus Genes       Date:  2003-01       Impact factor: 2.332

3.  Molecular characteristics of human immunodeficiency virus type 1 subtype C viruses from KwaZulu-Natal, South Africa: implications for vaccine and antiretroviral control strategies.

Authors:  M Gordon; T De Oliveira; K Bishop; H M Coovadia; L Madurai; S Engelbrecht; E Janse van Rensburg; A Mosam; A Smith; S Cassol
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

4.  In vitro hypersusceptibility of human immunodeficiency virus type 1 subtype C protease to lopinavir.

Authors:  Luis M F Gonzalez; Rodrigo M Brindeiro; Michelle Tarin; Alexandre Calazans; Marcelo A Soares; Sharon Cassol; Amilcar Tanuri
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

5.  Evidence for heterogeneous selective pressures in the evolution of the env gene in different human immunodeficiency virus type 1 subtypes.

Authors:  Simon A A Travers; Mary J O'Connell; Grace P McCormack; James O McInerney
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  UCLA1, a synthetic derivative of a gp120 RNA aptamer, inhibits entry of human immunodeficiency virus type 1 subtype C.

Authors:  Hazel T Mufhandu; Elin S Gray; Maphuti C Madiga; Nancy Tumba; Kabamba B Alexandre; Thandeka Khoza; Constantinos Kurt Wibmer; Penny L Moore; Lynn Morris; Makobetsa Khati
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

7.  The explosive human immunodeficiency virus type 1 epidemic among injecting drug users of Kathmandu, Nepal, is caused by a subtype C virus of restricted genetic diversity.

Authors:  R B Oelrichs; I L Shrestha; D A Anderson; N J Deacon
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 8.  Factors Driving the HIV Epidemic in Southern Africa.

Authors:  Lyle R McKinnon; Quarraisha Abdool Karim
Journal:  Curr HIV/AIDS Rep       Date:  2016-06       Impact factor: 5.071

9.  HIV-1 subtype C is not associated with higher risk of heterosexual HIV-1 transmission: a multinational study among HIV-1 serodiscordant couples.

Authors:  Erin Kahle; Mary Campbell; Jairam Lingappa; Deborah Donnell; Connie Celum; Raphael Ondondo; Andrew Mujugira; Kenneth Fife; Nelly Mugo; Saidi Kapiga; James I Mullins; Jared M Baeten
Journal:  AIDS       Date:  2014-01-14       Impact factor: 4.177

10.  Variability at human immunodeficiency virus type 1 subtype C protease cleavage sites: an indication of viral fitness?

Authors:  Tulio de Oliveira; Susan Engelbrecht; Estrelita Janse van Rensburg; Michelle Gordon; Karen Bishop; Jan zur Megede; Susan W Barnett; Sharon Cassol
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.